Vés al contingut

An open-label, multiple dose, multicenter study to evaluate the pharmacokinetics, safety, and tolerability of filgotinib in children and adolescents from 8 to less than 18 years of age with juvenile idiopathic arthritis

Obert
  • Codi protocol: GLPG0634-CL-131
  • Codi EudraCT: No aplica
  • Grup de recerca: Reumatologia
  • Servei: Medicina Interna
  • Investigador/a principal:  Lopez Corbeto, Mireia
  • Fase: Fase I
  • Estat: Reclutant voluntaris